Webinars

DEC 12, 2019 9:00 AM PST

Psychiatric Pharmacogenomics: Practical Applications for the Community Psychiatrist

Speaker

Event Date & Time

DATE: December 12, 2019 - December 12, 2020

This activity is provided by Global Education Group.

Abstract

The Community Psychiatrist is at the vanguard of the mental health crisis afflicting the nation, providing care to the patients where it is most needed. It is in this scenario where we see the day to day struggle of the everyday psychiatric patient who encounters treatment resistance, or a plethora of side effects, which may curtail the desire of the average patient, already stigmatized by society because of their mental illness, from seeking proper Psychiatric care. Psychiatric Pharmacogenomics is a tool in the armamentarium of the Community Psychiatrist to cut through that treatment resistance, limit side effects, and ultimately, improve outcomes for the patients in the community who experience unnecessary hardships brought about by their oft difficult to treat conditions. There are certain genes and genotypes which we will review that are relevant to test for patients with psychiatric issues. There are practical applications for these tests which can justifiably be utilized after repeated treatment failure or experiencing vicious side effects, and in some cases, even prior to embarking a medication trial. Finally, there are basic resources on pharmacogenomic drug information that a well informed psychiatrist should be aware of when prescribing psychotropics that can guide treatment in the present and moving forward.

Learning Objectives:

Discuss the difference between pharmacokinetics and pharmacodynamics
Describe certain Cytochrome p450 substrates, inducers, and inhibitors that affect drug metabolism, and online resources to help you negotiate these issues
Evaluate PharmGKB and find genes and meds that might help you guide your treatment
Explain why the patient might be right and Lithium might not always be the “gold standard” in treatment

Continuing Medical Education (CME) Credits:

Target Audience
The educational design of this activity addresses the needs of MDs, PhDs, and typical community psychiatrists seeing patients from 9 to 5, doing psychopharmacology work

Physician Accreditation Statement
Global Education Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physician Credit Designation
Global Education Group designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Term of Offering
This activity was released on 12/12/2019 and is valid for one year. Requests for credit must be made no later than 12/12/2020.

Global Contact Information
For information about the accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.

Instructions for Obtaining Credit
In order to receive credit, participants must view the entire webinar, and then complete both the evaluation and posttest, at which time they will be sent a certificate via email for downloading.

Disclosure of Conflicts of Interest
Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

*Name of Faculty or Presenter*	*Reported Financial Relationship*
Joachim Benitez	Nothing to disclose

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

*Name of Planner or Manager*	*Reported Financial Relationship*
Lindsay Borvansky	Nothing to disclose
Andrea Funk	Nothing to disclose
Liddy Knight	Nothing to disclose
Ashley Cann	Nothing to disclose
Tracy Salcido	Nothing to disclose

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and LabRoots do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

* There is no fee for this educational activity

Psychiatric Pharmacogenomics: Practical Applications for the Community Psychiatrist

Loading Comments...

Content Tags

Attendees

Psychiatric Pharmacogenomics: Practical Applications for the Community Psychiatrist

Joachim Benitez, MD

Psychiatric Pharmacogenomics: Practical Applications for the Community Psychiatrist